Thompson Davis & Co., Inc. Co Diagnostics, Inc. Transaction History
Thompson Davis & Co., Inc.
- $153 Million
- Q4 2024
A detailed history of Thompson Davis & Co., Inc. transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 57,200 shares of CODX stock, worth $34,892. This represents 0.03% of its overall portfolio holdings.
Number of Shares
57,200
Previous 41,500
37.83%
Holding current value
$34,892
Previous $51,000
17.65%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.08 Million0.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$720,7960.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$338,9290.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$306,2350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$210,7610.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $20.6M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...